SCHEMBL4929409

SCHEMBL4929409

CCC(C)Nc1cc(COc2c(Cl)cc(NC(=O)CC(=O)O)cc2Cl)cc(C(F)(F)F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
LMNA P02545 1/20 0.40
MRGPRX4 Q96LA9 6/20 0.39
TACR1 P25103 1/20 0.39
MME P08473 1/20 0.39
ACE P12821 1/20 0.39
CPA1 P15085 1/20 0.39
ACE2 Q9BYF1 1/20 0.39
RHOC P08134 1/20 0.37
RHOA P61586 1/20 0.37
THRA P10827 2/20 0.35
THRB P10828 2/20 0.35
ACP1 P24666 1/20 0.34
JUN P05412 1/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
KDR P35968 1/20 0.34
MAPK14 Q16539 1/20 0.34
TNNI3K Q59H18 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4931997 0.91 ALDH1A1 (0.46) ALDH1A1LMNAMRGPRX4TACR1MME
SCHEMBL4929469 0.90 ALDH1A1 (0.43) ALDH1A1LMNAMRGPRX4TACR1MME
SCHEMBL4932697 0.89 ALDH1A1 (0.44) ALDH1A1LMNAMRGPRX4TACR1MME
SCHEMBL5717945 0.89 THRB (0.38) ALDH1A1MRGPRX4MMEACECPA1
SCHEMBL5111277 0.88 ALDH1A1 (0.46) ALDH1A1LMNAMRGPRX4TACR1RHOC
SCHEMBL5110736 0.87 ALDH1A1 (0.46) ALDH1A1LMNAMRGPRX4TACR1MME
SCHEMBL4922944 0.87 PPARD (0.43) ALDH1A1MRGPRX4MMEACECPA1
SCHEMBL4931623 0.87 MEN1 (0.40) ALDH1A1LMNAMRGPRX4THRATHRB
SCHEMBL4935433 0.86 TRPA1 (0.43) ALDH1A1LMNAMRGPRX4TACR1RHOC
SCHEMBL4924778 0.86 THRB (0.37) ALDH1A1MRGPRX4THRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA ALDH1A1 1818/4885LMNA 3893/4885MRGPRX4 119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.